Advanced glycation end products enhance inflammatory response of vascular adventitial fibroblasts and effect of candesartan
LIU Yayang,LIANG Chun,LIU Xing,PAN Xiaoming,REN Yusheng,FAN Min,WU Zonggui
2009-01-01
Abstract:Objective To investigate the effects and mechanism of advanced glycation end products(AGEs)on the inflammatory responses of rat vascular adventitial fibroblasts and the interventional effects of candesartan.Methods Isolated vascular adventitial fibroblasts of Sprague-Dawley(SD)rats were cultured.Expression of receptor for advanced glycation end products(RAGE)was examined by reverse transcriptase polymerase chain reaction(RT-PCR)and Western blotting assay.Expression of monoeyte chemoattractant protein(MCP)-1,interleukin(IL)-6,and vascuolar cell adhesion molecule(VCAM)-1 mRNA was also analyzed by RT-PCR.Levels of MCP-1,IL-6,and VCAM-1 in the supernatants were determined by enzyme-linked immunosorbent assay(ELISA).Nuclear factor(NF)-κB and inhibitory protein of NF-κB α(I-κB-α)was analyzed by electrophoretic mobility shift assay(EMSA)and Western blotting.Results AGE-human serum albumin(HSA)(50,100,150,200 and 300 mg/L)up-regulated the expression of RAGE at mRNA and protein levels in a concentration-dependent manner;the expression was significantly higher than those of the control group and HSA group(both P<0.05).The expression of RAGE peaked at the concentration of 200 mg/L,which was significantly higher than that of the other concentration groups(P<0.05).NF-κB transcriptional activity was increased after treatment with AGE-HSA(200 mg/L)for 0.5 h,1.0 h and 2.0 h.Incubation of AFs with AGE-HSA(200 mg/L)for 0.5 h and 1.0 h induced phosphorylation of I-κB-α.AGE-HSA(200 mg/L)treatment increased nuclear NF-κB;candesartan co-treatment inhibited this translocation.I-κB-α phosphorylation in response to AGE-HSA(200 mg/L)was also suppressed by candesartan.AGEs(50,100,200,and 300 mg/L)elevated the mRNA expression of MCP-1,IL-6,and VCAM-1.Compared with control,the expression of IL-6,VCAM-1,and MCP-1 mRNA increased significantly in AGE-HSA 50,100 mg/L groups(P<0.05)and AGE-HSA 200,300 mg/L groups(P<0.01).Pretreatment of the cells with anti-RAGE antibody,MG-132,an inhibitor of NF-κB,and candesartan decreased the AGE-HSA induced expression and supernatant levels of IL-6,VCAM-1,and MCP-1(P<0.05).Conclusion It is indicated that AGEs can increase the expression of MCP-1,IL-6,and VCAM-1 in AFs via RAGE and NF-κB pathways.Candesartan can effectively inhibit phosphorylation of I-κB-α,nuclear translocation of NF-κB and expression of inflammatory factors,suggesting it has a therapeutic effect on vascular complication of diabetes.